Effective April 1, 2024, the U.S. Department of Agriculture’s Food Safety and Inspection Service (USDA’s FSIS) will exclude current commercial vaccine subtypes of Salmonellaconfirmed in FSIS raw poultry samples from the calculation used to categorize establishments under the raw poultry Salmonella performance standards. FSIS Salmonella performance standards are assessed on broiler carcasses, turkey carcasses, comminuted chicken, comminuted turkey, and chicken parts.
In December 2021, FSIS announced that it would be inviting poultry slaughter and processing establishments to submit proposals for pilot projects to test different strategies for Salmonella control in poultry products. Since March 2023, FSIS has granted pilot projects to nine establishments to examine the merits and logistics of excluding Salmonella poultry vaccine strains from the FSIS Salmonella performance categorization calculation.